The makers of Tylenol have a new parent company. Kenvue, the acetaminophen manufacturer, announced that company Kimberly-Clark has acquired the consumer health brand. Kimberly-Clark is buying Kenvue ...

Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a massive consumer ...

Kimberly-Clark CEO Mike Hsu discussed his company's $48.7 billion acquisition of Kenvue in a Monday interview with CNBC's Jim Cramer.

The consumer products giant reached a $40 billion deal to buy Kenvue, the maker of Tylenol, despite a barrage of unproven ...

One of biggest takeovers so far this year will create a global company with annual revenues of roughly $32 billion.

The announcement comes weeks after President Trump made claims linking Tylenol to autism in pregnant women's unborn babies, ...

Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a massive consumer ...

New research shows no causal link between Tylenol use during pregnancy and autism. Experts say acetaminophen remains safe for occasional use as directed under medical guidance.

The owner of Kleenex and Huggies will acquire the embattled company, which has fought claims by the Trump administration that a common pain reliever is linked to harmful side effects.

Although Kimberly-Clark suffered a huge blow after announcing its Kenvue buyout, KMB stock is flashing a quantitative ...

One of the biggest mergers of the year, worth $49 billion, comes just weeks after the Trump administration linked the common ...